Skip to main content
TipRanks
Go Ultimate75% OFF

David Burgstahler Insider Profile

4 Followers

David Burgstahler, Director at AngioDynamics, holds 23.73M shares in RVL Pharmaceuticals (Ticker: RVLPQ), holds 35.39K shares in Wideopenwest (Ticker: WOW), holds 17.79M shares in Lantheus (Ticker: LNTH).

David Burgstahler's Trading History

RVLPQ
RVL Pharmaceuticals
Jan 30, 2023―Uninformative Sell――
WOW
Wideopenwest
Jan 10, 2018―Uninformative Buy―$184.01K
LNTH
Lantheus
Sep 11, 2017DirectorInformative Sell1.70M$1.81B
SYNH
Syneos Health
May 24, 2017―Uninformative Buy―$1.12B
ANGO
AngioDynamics
Apr 14, 2017DirectorInformative Sell37.60M$111.34M
WCRX
Warner Chilcott
――――

You May Also Like

David Burgstahler insider profile FAQ

What is the percentage of profitable transactions made by David Burgstahler?
The percentage of profitable transactions made by David Burgstahler is 53%.
What is the average return per transaction made by David Burgstahler?
The average return per transaction made by David Burgstahler is -5.10%.
What stocks does David Burgstahler hold?
David Burgstahler holds: ANGO, LNTH, WOW, RVLPQ, SYNH, WCRX stocks.
What was David Burgstahler's most profitable transaction?
David Burgstahler’s most profitable transaction was an Informative Buy of SYNH stock on November 6, 2014. The return on the trade was 137.90%.
What is David Burgstahler's role in AngioDynamics?
David Burgstahler's role in AngioDynamics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.